Close

Drug Research

Transgenomic to advance pancreatic cancer research with NIH grant

Transgenomic, a global biotechnology company, has won $100,000 small business technology transfer programme (STTR) Phase I grant from National Institutes of Health's (NIH)...

US FDA approves Wockhardt hypertension drug

Wockhardt has received final approval from the US Food and Drug Administration ((FDA) to market extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine,...

RayBiotech screening assays used to identify chemoresistance pathway

RayBiotech-developed antibody-based biomarker screening assays have been used to identify a critical pathway involved in chemotherapeutic resistance acquired by melanoma cancer cells. ...

Elsevier integrates Reaxys with electronic laboratory notebook

PerkinElmer has integrated its electronic laboratory notebook (ELN) with Elsevier's Reaxys, a web-based workflow solution designed for chemistry researchers in drug discovery, chemicals...

Alnylam and Ascletis collaborate to develop ALN-VSP for liver cancers in China

Alnylam Pharmaceuticals and Ascletis Pharmaceuticals have entered into a partnership to develop a systemically delivered RNAi therapeutic, ALN-VSP, for the treatment of liver...

Takeda signs Omontys injection supply contract with Fresenius

Takeda Pharmaceuticals America (TPA) has signed a contract to supply Omontys injection to Fresenius Medical Care North America and certain of its affiliates....

Boehringer, Eli Lilly to launch diabetes drug in India

Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name trajenta) 5mg film-coated tablets, for Type 2 diabetes in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read